OT-202
/ Ocumension Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 30, 2024
Study of OT202 in Treating Moderate to Severe Dry Eye
(clinicaltrials.gov)
- P2 | N=213 | Completed | Sponsor: Ocumension Therapeutics (Shanghai) Co., Ltd
New P2 trial • Dry Eye Disease • Ophthalmology
1 to 1
Of
1
Go to page
1